CSF1R and neoplasm: Utilizing the treatment regimen outlined in Fig. 3a, we observed a sharp increase in CSF1 serum levels following treatment with 500 ug of anti-CSF1R in the MC38 tumor model, which is characteristic of receptor occupancy by the antibody (Fig. 3b).